Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the period from August 1 to August 31, 2020. The report discloses consolidated transactions of securities and derivatives involving the company's Board of Directors, Management, and Fiscal Council, in compliance with Article 11 of CVM Instruction # 358/2002.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on insider trading activity.
| Group | Transaction Type | Security | Total Quantity | Total Volume (R$) |
|---|---|---|---|---|
| Board of Directors | Buy | ADR Common | 500,000 | R$ 11,262,418.03 |
| Management | None | N/A | 0 | R$ 0 |
| Fiscal Council | None | N/A | 0 | R$ 0 |
Material Changes
During the reporting month, the Board of Directors increased their aggregate holding of American Depositary Receipts (ADR) Common by 500,000 units through four separate purchase transactions executed via JP Morgan. No changes were reported for Management or the Fiscal Council.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or contingencies. It is a regulatory disclosure of specific securities transactions.
Investor Verification Checklist
- Verify the aggregate ADR holdings of the Board of Directors post-transaction (1,003,738 ADRs).
- Confirm the average purchase price of the ADRs acquired by the Board (approximately R$ 13.00 - R$ 13.53 per unit).
- Note that Management and the Fiscal Council held no new transactions during this period.
- Confirm that no stock options (ABEVF13 or ABEVF42) were exercised or held by the reporting groups.